Should all pregnant women be given antimalarial drugs? Evidence update - Summary of a Cochrane Review

LSTM International Public Health

Should all pregnant women be given antimalarial drugs? Evidence update - Summary of a Cochrane Review

LSTM International Public Health

International Public Health

Research output: Other contribution

Abstract

In women in their first or second pregnancy, antimalarial drugs given routinely reduce severe anaemia in the mother and there are fewer perinatal deaths.

Original language	English
Publisher	Liverpool School of Tropical Medicine
Publication status	Published - 1 Jan 2008

Access to Document

MH Malaria-in-preg CD000169 JAN08Final published version, 139 KBLicence: CC BY-ND

Cite this

@misc{2e6dc3566b924df092eb3b80962ad9b4,

title = "Should all pregnant women be given antimalarial drugs? Evidence update - Summary of a Cochrane Review",

abstract = "In women in their first or second pregnancy, antimalarial drugs given routinely reduce severe anaemia in the mother and there are fewer perinatal deaths.",

author = "\{International Public Health\}, LSTM",

year = "2008",

month = jan,

day = "1",

language = "English",

publisher = "Liverpool School of Tropical Medicine",

type = "Other",

}

TY - GEN

T1 - Should all pregnant women be given antimalarial drugs? Evidence update - Summary of a Cochrane Review

AU - International Public Health, LSTM

PY - 2008/1/1

Y1 - 2008/1/1

N2 - In women in their first or second pregnancy, antimalarial drugs given routinely reduce severe anaemia in the mother and there are fewer perinatal deaths.

AB - In women in their first or second pregnancy, antimalarial drugs given routinely reduce severe anaemia in the mother and there are fewer perinatal deaths.

M3 - Other contribution

PB - Liverpool School of Tropical Medicine

ER -

Should all pregnant women be given antimalarial drugs? Evidence update - Summary of a Cochrane Review

Abstract

Access to Document

Fingerprint

Cite this